Caption Management, LLC Tg Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$8.03 Billion
Q2 2025

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$33.37 - $45.51 $694,096 - $946,608	20,800 Added 194.39%	31,500 $1.13 Million
Q1 2025 May 15, 2025	SELL	$27.67 - $42.99 $3.11 Million - $4.84 Million	-112,500 Reduced 91.31%	10,700 $421,000
Q4 2024 Feb 14, 2025	BUY	$21.31 - $35.09 $1.99 Million - $3.27 Million	93,200 Added 310.67%	123,200 $3.71 Million
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $516,300 - $758,400	30,000 New	30,000 $701,000
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $3.43 Million - $5.61 Million	-263,600 Reduced 91.91%	23,200 $352,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $733,464 - $2.07 Million	109,800 Added 62.03%	286,800 $4.9 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $2.53 Million - $8.03 Million	-302,900 Reduced 63.12%	177,000 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $4.24 Million - $9.58 Million	273,800 Added 132.85%	479,900 $11.9 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $11.8 Million - $22.2 Million	-1,149,900 Reduced 84.8%	206,100 $3.1 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $6.08 Million - $14.4 Million	1,214,300 Added 856.95%	1,356,000 $16 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $2.13 Million - $3.91 Million	-465,000 Reduced 76.64%	141,700 $838,000
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $1.59 Million - $4.53 Million	425,100 Added 234.09%	606,700 $2.58 Million
Q1 2022 May 13, 2022	BUY	$7.81 - $20.45 $1.07 Million - $2.79 Million	136,600 Added 303.56%	181,600 $1.73 Million
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $1.2 Million - $2.22 Million	-55,000 Reduced 55.0%	45,000 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $8.8 Million - $13.3 Million	-270,900 Reduced 73.04%	100,000 $3.88 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $494,088 - $1.11 Million	69,200 Added 22.94%	370,900 $3.65 Million
Q4 2019 Feb 13, 2020	BUY	$5.1 - $11.2 $1.54 Million - $3.38 Million	301,700 New	301,700 $3.35 Million
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $801,620 - $1.34 Million	-149,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $934,229 - $1.29 Million	149,000 New	149,000 $1.29 Million
Q4 2018 Jan 30, 2019	SELL	$3.44 - $5.76 $601,656 - $1.01 Million	-174,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $900,735 - $2.45 Million	174,900 New	174,900 $979,000

Others Institutions Holding TGTX

# of Institutions

406

Shares Held

92.4M

Call Options Held

2.28M

Put Options Held

1.78M

Vanguard Group Inc Valley Forge, PA

15.8M
Shares

$580 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$418 Million
0.0% of portfolio
State Street Corp Boston, MA

7.62M
Shares

$280 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

3.49M
Shares

$128 Million
0.01% of portfolio
Clearbridge Investments, LLC New York, NY

3.05M
Shares

$112 Million
0.09% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.33B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account